The DZHK is headed by a three-member Board of Directors.The term of office of the board is three years and can be extended once. The board is elected by the general meeting. As a rule, the work in the board is not full-time.
Chairman of the BoardProf. Thomas Eschenhagen
Member of the BoardProf. Steffen Massberg
Klinikum der Universität München
Member of the BoardProf. Thomas Sommer
Max-Delbrück-Centrum für Molekulare Medizin